HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,213,926 | -66.8% | 14,258 | -67.7% | 0.03% | -68.0% |
Q1 2023 | $3,658,129 | -28.6% | 44,207 | -32.1% | 0.10% | -31.0% |
Q4 2022 | $5,120,194 | +380.3% | 65,101 | +352.2% | 0.14% | +291.9% |
Q3 2022 | $1,066,000 | -87.1% | 14,396 | -88.6% | 0.04% | -90.0% |
Q2 2022 | $8,241,000 | +3715.3% | 126,439 | +3604.6% | 0.37% | +3590.0% |
Q1 2022 | $216,000 | -48.2% | 3,413 | -56.6% | 0.01% | -61.5% |
Q4 2021 | $417,000 | +19.8% | 7,869 | +168.8% | 0.03% | -29.7% |
Q4 2020 | $348,000 | -17.9% | 2,928 | -39.7% | 0.04% | +37.0% |
Q3 2020 | $424,000 | -42.5% | 4,857 | -24.3% | 0.03% | -38.6% |
Q4 2019 | $737,000 | -22.3% | 6,417 | -14.7% | 0.04% | -46.3% |
Q3 2019 | $949,000 | -10.3% | 7,526 | -37.8% | 0.08% | +9.3% |
Q1 2019 | $1,058,000 | +344.5% | 12,093 | +481.4% | 0.08% | +316.7% |
Q3 2018 | $238,000 | -92.7% | 2,080 | -94.3% | 0.02% | -92.0% |
Q2 2018 | $3,261,000 | +139.6% | 36,365 | +95.4% | 0.23% | +137.9% |
Q1 2018 | $1,361,000 | +194.6% | 18,609 | +80.6% | 0.10% | -18.1% |
Q3 2017 | $462,000 | +71.7% | 10,302 | +54.2% | 0.12% | +169.8% |
Q4 2016 | $269,000 | -25.5% | 6,682 | -46.3% | 0.04% | -8.5% |
Q2 2016 | $361,000 | -7.7% | 12,445 | +2.9% | 0.05% | +38.2% |
Q3 2015 | $391,000 | – | 12,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |